CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRIS…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
CRISPR Therapeutics AG has no obligation with a government/award agency.
Latest Obligations
Spending By Type
CRISPR Therapeutics AG can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of CRISPR Therapeutics AG.